The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: Why most self-reports here are not experiments, and that is fine

This is a generated summary. It shows the 9 most-liked posts from a topic of 63, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
TK
t.kulkarniTL3Regular Solution7 Sep 2025#4

post #2 answers the question as asked. The question underneath it is different.

Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people different from you.

7 likes 11mo
B
BDraganovTL2Member28 Sep 2025 · edited#8
t.kulkarni, post #4: post #2 answers the question as asked. The question underneath it is different. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people different from you. Go to post

post #7 is right about the mechanism and I think understates the practical bit.

Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less vulnerable but not immune.

25 likes in reply to #4 10mo
PK
p.krastevTL2 Moderator2 Oct 2025 · edited#9

Coming back to post #7, because the follow-up matters more than the original answer.

Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.

24 likes 10mo
AA
a.amankwahTL2 Moderator10 Nov 2025#18
p.krastev, post #9: Coming back to post #7, because the follow-up matters more than the original answer. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid. Go to post

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

32 likes in reply to #9 9mo
PK
p.krastevTL2 Moderator10 Dec 2025#26

This follows post #23 rather than contradicting it.

Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less vulnerable but not immune.

29 likes 8mo
CR
c.ramosTL2 Moderator7 Jan 2026#34

Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what you already believed has not changed anything.

31 likes 7mo
MM
methods_marginTL3Regular3 Feb 2026#42

Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met). Not deciding in advance means stopping when the result satisfies you, which is bias.

24 likes 6mo
GP
g.pemberton_ukTL3Regional · UK15 Feb 2026#46

post #45 answers the question as asked. The question underneath it is different.

Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less vulnerable but not immune.

32 likes 5mo
FH
f.haddadTL2 Moderator13 Mar 2026#54

Worth separating two things that post #50 runs together.

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

25 likes 5mo

Read the full topic (63 posts)

This topic was closed 45 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
Designing a personal experiment that could change your mind
Posting this under the heading it deserves: Designing a personal experiment that could change your mind Everything below is what sits behind that. Session topic: STEP 8 ( JAMA , 2022). Please read it before…
MGECFACHG+2 6 695 6mo
Washout with a one-week half-life: the arithmetic
Washout with a one-week half-life: the arithmetic — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not think it…
SKTPBLCSF+90 96 44k 20mo
Washout with a one-week half-life: the arithmetic — does this still hold?
Washout with a one-week half-life: the arithmetic — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
AFANABANNN+41 45 12k 1d
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before…
VELIGRAC+106 118 25k 4mo
Pre-registering a personal experiment, seriously
Pre-registering a personal experiment, seriously — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SUSTAIN 6 ( N Engl J Med , 2016) and finding the…
PADAVSSJL+96 119 58k 14mo

Related topics — sharing the tags worked example, data table, effect size

TopicParticipantsRepliesViewsActivity
Triple agonism: additive, synergistic, or neither?
The question in the title: Triple agonism: additive, synergistic, or neither? I will give what I have already checked below so nobody repeats it. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
EKEPAKTWJD+71 80 38k 11mo
Revisiting: Sample size in a voluntary survey: the selection problem
Revisiting: Sample size in a voluntary survey: the selection problem — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies…
RAZAR 2 56k 9mo
Blinding yourself: practical methods and their limits — the long version
Blinding yourself: practical methods and their limits — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024)…
CTSDNGJEMD+7 11 1.8k 22h
Restarting after a long gap: what the labelling implies
Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the maintained page on this and I still have a gap,…
RBIDELKKHN+41 46 11k 15h
Revisiting: Holding a dose indefinitely: is there a documented downside?
The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it. A question about technique rather than…
MVBVPKCC+26 30 4.5k 18mo